News

Institutional Review Board Approves Regenative Labs’ Protocol For Key Data Collection
Tyler Barrett, CEO of Regenative Labs
Regenative Labs Receives First National Medicare/Medicaid Insurance Reimbursement Approval for Wharton’s Jelly Allografts
« Previous Page